Postpartum Cardiomyopathy Belinda Ortiz West Coast University NURS 540 Professor Knapp July

Postpartum Cardiomyopathy

Belinda Ortiz

West Coast University

NURS 540

Professor Knapp

July 16, 2023

Introduction:

Heart failure is the hallmark of postpartum cardiomyopathy (PPCM). This uncommon but potentially fatal illness develops in the final month of pregnancy or within the first five months following childbirth. Due to a lack of knowledge about its risk factors and prognostic markers, PPCM still presents substantial hurdles to healthcare providers despite advancements in prenatal care (da Rosa et al., 2014). Including its origin, risk factors, and diagnostic indicators, the multifaceted characteristics of PPCM are explored in this literature review.

Etiology of Postpartum Cardiomyopathy:

PPCM’s precise etiology still needs to be discovered despite several possibilities. According to one theory, hormonal, genetic, immunologic, and environmental variables may interact to cause PPCM (Rodriguez et al., 2020). According to a different notion Hilfiker-Kleiner et al. (2015), releasing angiogenic and anti-angiogenic substances during pregnancy may impair cardiac remodeling and cause PPCM. More study is required to understand the intricate mechanisms behind the development of PPCM.

Risk Factors for Postpartum Cardiomyopathy:

A higher chance of having PPCM has been linked to several risk factors. Significant risk factors include advanced maternal age, multiparity, African ancestry, preeclampsia, and gestational hypertension ((Bhakta et al., 2007); Capriola, 2012). A family history of PPCM, obesity, and numerous pregnancies are other possible risk factors (Haghikia et al., 2013). It is helpful to be aware of these risk factors to identify high-risk individuals and execute effective preventative measures.

Predictive Indicators for Postpartum Cardiomyopathy:

For early identification and effective intervention, PPCM predictive markers must be identified. According to Llurba et al. (2015) and Haghikia et al. (2013), soluble fms-like tyrosine kinase-1 (sFLT-1) and brain natriuretic peptide (BNP) are three biomarkers that have shown potential in predicting the onset of PPCM. Also examined as possible predictors of PPCM are echocardiographic measurements of left ventricular global longitudinal strain (LVGLS) and left ventricular ejection fraction (LVEF) (Llurba et al., 2015; Blauwet et al., 2016). However, more investigation is required to confirm these prognostic signs and ascertain their therapeutic applicability.

How can we use this information to improve the prevention, early detection, and treatment of PPCM?

The information provided in the literature review can be used to improve the prevention, early detection, and treatment of postpartum cardiomyopathy (PPCM) in the following ways:

Prevention:

a. Identifying Risk Factors: By recognizing the risk factors connected to PPCM, such as advanced maternal age, multiparity, preeclampsia, and gestational hypertension, healthcare professionals can identify high-risk individuals. One can utilize targeted interventions, such as careful monitoring throughout pregnancy and postpartum, altering one’s lifestyle, and resolving current issues.

b. Education and Awareness: Healthcare providers may explain to expecting mothers and their families the signs and symptoms of PPCM, emphasizing the need to seek quick medical attention if any concerning symptoms manifest.

Early Detection:

a. Predictive Indicators: The discovery and confirmation of biomarkers, such as cardiac troponins, BNP, and sFLT-1, as well as echocardiographic parameters, such as LVEF and LVGLS, can aid in the early diagnosis of PPCM. These signs can detect patients when high-risk individuals are routinely checked early, enabling prompt intervention and care.

b. Symptom Recognition: By increasing healthcare practitioners’ understanding of the clinical presentation of PPCM, early identification can be enhanced. Patients who report symptoms such as dyspnea, fatigue, edema, and palpitations should have an urgent evaluation and diagnostic testing in the latter stages of pregnancy or postpartum.

Treatment:

a. Multidisciplinary Approach: To effectively manage PPCM, obstetricians, cardiologists, and other medical experts must work together. Creating a multidisciplinary team can help with prompt diagnosis, thorough evaluation, and effective treatment planning.

b. Medication and Therapy: PPCM can be managed using evidence-based treatment approaches, such as drugs for heart failure that are advised by guidelines. PPCM patients can receive comprehensive therapy from cardiac rehabilitation programs and specialist cardiac care facilities(Kim & Shin, 2017).

c. Emotional and Psychosocial Support: The emotional toll that PPCM has on afflicted women and their families may be profound. Giving patients access to support groups, counseling, and emotional support can benefit their general well-being and treatment process.

By incorporating this knowledge into clinical practice and healthcare guidelines, healthcare workers may better comprehend PPCM and develop preventive measures, early detection techniques, and treatment timelines. This could lower the morbidity and mortality linked to PPCM, leading to better outcomes for women with this illness.

Implications for Nursing Practice:

Nursing is essential for women during the perinatal period, including identifying and managing issues like PPCM. Nurses are better equipped to assess patients, offer pertinent advice and education, and support early treatments if they know the risk factors and prediction markers linked to PPCM. Nurses can help to lessen the prevalence and effects of PPCM on maternal outcomes by identifying high-risk people and delivering focused treatments.

Conclusion:

The significance of investigating the multifaceted elements of PPCM, such as its genesis, risk factors, and prediction indications, is highlighted by this literature review. Creating comprehensive management plans, successful early detection tactics, and preventative programs can be influenced by an increased understanding of these fields. This study endeavor can potentially increase postpartum care quality and maternal outcomes, leading to better healthcare for women afflicted by PPCM through advancing nurse practice and evidence-based treatment. Expanding our knowledge of PPCM and its contributing variables would help healthcare practitioners treat women at risk more precisely.

References

Bhakta, P., Biswas, B. K., & Banerjee, B. (2007). Peripartum Cardiomyopathy: Review of the Literature. Yonsei Medical Journal, 48(5), 731. https://doi.org/10.3349/ymj.2007.48.5.731

Capriola, M. (2012). Peripartum cardiomyopathy: a review. International Journal of Women’s Health, 1. https://doi.org/10.2147/ijwh.s37137

da Rosa, C. Q., da Silveira, D. S., & da Costa, J. S. D. (2014). Factors associated with lack of prenatal care in a large municipality. Revista de Saúde Pública, 48(6), 977–984. https://doi.org/10.1590/S0034-8910.2014048005283

Halkein, J., Tabruyn, S. P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.-Q.-N., Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Thiry, M., Sliwa, K., Noel, A., Martial, J. A., Hilfiker-Kleiner, D., & Struman, I. (2013). MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. Journal of Clinical Investigation, 123(5), 2143–2154. https://doi.org/10.1172/jci64365

Hilfiker-Kleiner, D., Haghikia, A., Nonhoff, J., & Bauersachs, J. (2015). Peripartum cardiomyopathy: current management and future perspectives. European Heart Journal, 36(18), 1090–1097. https://doi.org/10.1093/eurheartj/ehv009

Kim, M.-J., & Shin, M.-S. (2017). Practical management of peripartum cardiomyopathy. The Korean Journal of Internal Medicine, 32(3), 393–403. https://doi.org/10.3904/kjim.2016.360

Llurba, E., Crispi, F., & Verlohren, S. (2015). Update on the Pathophysiological Implications and Clinical Role of Angiogenic Factors in Pregnancy. Fetal Diagnosis and Therapy, 37(2), 81–92. https://doi.org/10.1159/000368605

Rodriguez Ziccardi, M., & Siddique, M. S. (2020). Peripartum Cardiomyopathy. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482185/